Vivek Sharma – CEO, Piramal Pharma Solutions (PPS)
Vivek Sharma, CEO of Piramal Pharma Solutions (PPS), one of the world’s leading CDMOs with a presence in North America, Europe, and Asia, provides insights into the main trends shaping…
Address: W-199-E, MIDC Khairne, Thane Belapur Road,Navi Mumbai – 400705.,India
Tel: +91-22-4151 5151
Web: http://www.nilsan-nishotech.com/
The Company Started in 1989 as a PROCESS ENGINEERING COMPANY & is today one of the most accomplished and diversified business houses in India having head office in Mumbai , branch office at Hyderabad. At NILSAN Nishotech we have two SBU’S SEPTECH & EPMG. The Group’s success has been driven by the company’s commitment to delivering innovation and excellence. Through the consistent application of this commitment and a century of ethical business conduct, Nilsan Nishotech has earned an unparalleled reputation for trust a,nd reliability.
In 23 years, NILSAN Nishotech is the first company in India to develop the technology to support Pharma, Bio-Pharma , Sugar , Food & Healthcare customers; this spirit of innovation has continued throughout the organization’s history. Today NILSAN Nishotech is delivering exciting engineering innovative solutions across a spectrum of businesses. The company’s pursuit of excellence is equally well established and enduring. NILSAN Nishotech’s management understands that the company’s greatest asset is the trust and faith that customers have reposed in it, and recognizes that the company must continue to earn this trust. This translates to the organization delivering outstanding quality and value in everything it does. We have Overseas association with French Company Novasep (Chromatography Columns) , Austar –China (RO+EDI Skid) , Ziemann –India (Tanks) , DrM – Switzerland (Candle Filtration System) for which we stand one point contact in India.
Sterile Process Piping, Separation Technologies, Pharma Water Technologies
Vivek Sharma, CEO of Piramal Pharma Solutions (PPS), one of the world’s leading CDMOs with a presence in North America, Europe, and Asia, provides insights into the main trends shaping…
Swati Jajodia, managing director of Swati Spentose discusses her commitment to tackling underserved diseases and the company’s approach to bringing pentosan polysulfate to global markets while working with Key Opinion…
Jai and Sameer Hiremath of Hikal provide insights into the main trends shaping the Indian and global CDMO industry. They articulate how Hikal’s long-standing focus on quality standards, regulatory compliance,…
Dr. Hemant Koshia, commissioner of the FDCA Gujarat, the regulatory authority of the state of Gujarat – India’s leading hub for the production of pharmaceutical and healthcare products – provides…
Dr. Georges Jabre, the recently appointed CEO of Serdia Pharmaceuticals (India) Pvt. Ltd. (an affiliate of the Servier Group) and president of the Healthcare Committee of the Indo-French Chamber of…
Bharat V. Daftary, chairman and MD of Bharat Serums & Vaccines (BSV), a biopharmaceutical company with R&D units in USA, Germany & India and with a presence in over 76…
Yugal Sikri, chairman of the Pharmaceutical Management Program of the prestigious NMIMS University, and with an extremely rich experience in the pharmaceutical industry, explains his mission to build a valuable…
Raghuveer Kini, executive director of the Pharmaceuticals Export Promotion Council of India (Pharmexcil) provides insights into the key success factors that have allowed India to become the world’s pharmaceutical hub…
Jean-Pierre Baylet, country head for India and cluster head for South Asia at Sanofi Pasteur, provides insights into the progress and room for improvement that lie ahead for India’s immunization…
Dr. Deepak Sawant, Minister of Public Health and Family Welfare in the Government of Maharashtra, provides insights into some crucial achievements with regards to the state’s infant and child mortality…
The global pharmaceutical outsourcing market was estimated to be USD 115.7 billion in 2016, of which 49 percent is accounted for by contract research organisations (CROs). Within India, the contract…
In this exclusive interview, Binish Chudgar, vice-chairman and managing director of Intas, the largest privately-owned Indian pharmaceutical company with sales of over USD 1.7 billion during the last financial year,…
See our Cookie Privacy Policy Here